Fair Value Calculator Fair Value Calculator
EN DE

INDOFARM (INDOFARM) Fair Value & Analysis

Industrials · Market cap ₹7.0B

I INDOFARM INDOFARM · NSE
Price₹145.94
Fair Value₹93.40
Upside-36.0%
Quality35/100
Watch INDOFARM for free — get notified when fair value or trend changes. Watch for free
Evidence: Medium Range ₹73.96 – ₹121.42

Fair value as of: Jul 3, 2026

From 14 valuation models · updated today

Share price +15.1% over the past month.

Price vs Fair Value (12 months)

₹265.43 ₹111.16 Fair Value ₹93.40 Jul 2025 Jul 2026

12‑month range ₹111.16 – ₹265.43 · fair‑value band ₹73.96 – ₹121.42 · the ₹145.94 price screens above the ₹93.40 fair value. As of Jul 3, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

INDOFARM (INDOFARM) currently trades at ₹145.94, while our model-based Fair Value estimate is ₹93.40 — implying the stock looks roughly 36.0% overvalued today. We read business quality at 35/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, INDOFARM generated revenue of ₹4.4B at a net margin of 5.6%. Revenue grew 3.1% year over year. It earns a return on equity of 4.5%. Net debt stands at ₹734M. Fundamentals as of Jul 3, 2026

Key figures & financial health

Revenue (TTM) ₹4.4B
Revenue growth (YoY) +3.1%
Net margin 5.6%
Return on equity 4.5%
Free cash flow −₹118M FY2026
P/E ratio 28.4
More key figures
Operating margin 11.5%
EPS (TTM) ₹5.14
EPS growth (YoY) -44.6%
Net debt ₹734M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

INDOFARM reported revenue of ₹4.4B in FY2026 versus ₹3.5B in FY2022, a compound +5.8%/yr. Reported net income was ₹247M in FY2026, compounding +15.8%/yr from FY2022.

Revenue +5.8%/yr
FY22 ₹3.5B
FY23 ₹3.7B
FY24 ₹3.7B
FY25 ₹3.9B
FY26 ₹4.4B
Net income +15.8%/yr
FY22 ₹137M
FY23 ₹154M
FY24 ₹154M
FY25 ₹235M
FY26 ₹247M

Is INDOFARM fairly valued? → Check now

Similar stocks

6 more Farm & Heavy Construction Machinery stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).

Stock Price Fair Value vs Fair Value
Caterpillar Inc CAT $1,022 $307.83 -70%
Deere & Company DE $598.59 $186.23 -69%
DEER DEER C$30.59 C$8.93 -71%
Sany Heavy Industry Co SNHIY $11.25 $2.82 -75%
AB Volvo (publ), VLVLY $33.51 $27.98 -17%
PACCAR Inc PCAR $120.12 $94.80 -21%

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is INDOFARM (INDOFARM) undervalued?
As of Jul 3, 2026, our model estimates a fair value of ₹93.40 versus a price of ₹145.94 — about −36% (overvalued). Model-based estimate, not financial advice.
What is the fair value of INDOFARM?
Our model-based fair value for INDOFARM is ₹93.40 (as of Jul 3, 2026), built from audited fundamentals. The current price is ₹145.94.
What is the quality score of INDOFARM?
INDOFARM has a Quality Score of 35/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of INDOFARM (INDOFARM)?
INDOFARM reported trailing-twelve-month revenue of about ₹4.4B (latest available figure, as of Jul 3, 2026).
What is the net profit margin of INDOFARM?
The net profit margin of INDOFARM is about 5.6%, meaning it keeps roughly 5.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.